Last $11.87 USD
Change Today +0.46 / 4.03%
Volume 1.6M
MDXG On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

mimedx group inc (MDXG) Snapshot

Open
$11.41
Previous Close
$11.41
Day High
$11.97
Day Low
$11.23
52 Week High
12/19/14 - $11.97
52 Week Low
05/7/14 - $4.88
Market Cap
1.3B
Average Volume 10 Days
846.6K
EPS TTM
$0.01
Shares Outstanding
106.9M
EX-Date
--
P/E TM
1,183.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for MIMEDX GROUP INC (MDXG)

Related News

No related news articles were found.

mimedx group inc (MDXG) Related Businessweek News

No Related Businessweek News Found

mimedx group inc (MDXG) Details

MiMedx Group, Inc., together with its subsidiaries, designs, manufactures, and markets products and tissue processing services in the United States. The company’s products include patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies comprise AmnioFix and EpiFix, which are tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the company’s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. It processes the human amniotic membrane utilizing its proprietary PURION process to produce a safe and effective implant. The company also provides CollaFix, a medical device technology platform. It supplies amniotic tissue on OEM basis for application in the wound care, surgical, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force, independent sales representatives, and distributors, as well as through private label or OEM relationships. The company is headquartered in Marietta, Georgia.

222 Employees
Last Reported Date: 03/4/14

mimedx group inc (MDXG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $465.2K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $385.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $268.3K
Vice President, General Counsel and Consultan...
Total Annual Compensation: $240.0K
Compensation as of Fiscal Year 2013.

mimedx group inc (MDXG) Key Developments

MiMedx Group, Inc. Provides Earnings Guidance for the First Quarter of 2015 ; Revises Earnings Guidance for Full Year of 2015

MiMedx Group, Inc. provided earnings guidance for the first quarter and revised earnings guidance for full year of 2015. For the first quarter of 2015, the company expects revenues of $40 million to $41 million and operating profit margin to be in excess of 10%. The company raising its earlier forecast for 2015 revenue to range from $175 million to $190 million. The low end of its 2015 expectations represents approximately a 50% increase and the high end of its guidance represents approximately a 64% increase over its forecasted 2014 revenue. For the full year of 2015, the company expects operating profit margin to be in excess of 15%.

MiMedx Group, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 11:30 AM

MiMedx Group, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 11:30 AM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Parker H. Petit, Chairman and Chief Executive Officer.

MiMedx Group, Inc. Presents at Brean Capital Life Sciences Summit, Nov-24-2014

MiMedx Group, Inc. Presents at Brean Capital Life Sciences Summit, Nov-24-2014 . Venue: Convene (Formerly Sentry Centers), 730 3rd Avenue, New York, New York, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDXG:US $11.87 USD +0.46

MDXG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Shire PLC 4,629 GBp -53.00
View Industry Companies
 

Industry Analysis

MDXG

Industry Average

Valuation MDXG Industry Range
Price/Earnings 100.0x
Price/Sales 13.0x
Price/Book 15.6x
Price/Cash Flow 661.1x
TEV/Sales 12.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIMEDX GROUP INC, please visit www.mimedx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.